Nanomedicine & Women’s Health

Nanomedicine have the potential to revolutionize the diagnosis, prevention, and treatment of a range of conditions and diseases affecting women’s health

Nanomedicine is the application of nanotechnology in the field of medicine with a view to enhancing the diagnosis and treatment of various diseases. Nanotechnology is already involved in a range of biomedical applications including drug and vaccine delivery, diagnostic imaging, nanosensor diagnostics, nano-enabled therapies, and tissue engineering. A growing recognition of the specific health care requirements of women has resulted in the proposed organizational changes in the provision of health care, focusing predominantly on a life course approach to women’s health care. As our understanding of the benefits of nanomaterial-based agents and diagnostics continues to grow in terms of selectivity, sensitivity, affinity, and detection limits, there is a widespread anticipation that nanotechnology will play an increasing role in women’s health. 20th World Conference on Pharmaceutical Chemistry and Drug Design is going to be held in Dubai during September 03-05 2018,  under the enclosed title “Pharmaceutical Drug Discovery with Nanotechnology” is one among the multiple sessions where the speakers discuss regarding the particular topic.

The clear advancements being made in the field of NPs can, in part, be attributed to their highly favorable characteristics. A vital property of NPs is their ability to target a specific ligand/receptor of a cell. This adaptable feature of NPs allows researchers to manipulate the natural biology of diseased cells, creating NPs containing pharmaceuticals which can then target the specific diseased cells. Coupled with the enhanced surface area of NPs, this also leads to a greater ability to detect small numbers of cells, with specific target ligands/receptors in samples, and thus provides an excellent way of detecting disease. Furthermore, loading NPs with pharmaceuticals has been shown to improve the bioavailability of drugs, for example, by protecting the drugs from the internal environment, and therefore improving pharmacological performance. Loading can also lead to the sustained release of pharmaceuticals, as NPs can act as local deposits for drugs. This could thereby reduce noncompliance problems associated with drug efficacy. Although significant progress is being made, there are still many potential pitfalls in the translation of nanomedicine into clinical practice.

One of the most important issues is the potential toxicity of the particles themselves. These foreign, and synthetic, molecules are known to exhibit a variable degree of cytotoxic effects upon human cells. Further research must now concentrate on this potential barrier, focusing particularly on the composition of the NPs and the ligands present on their exterior, together with the metabolic fate of such particles. Particular emphasis should be directed toward finding techniques to form NPs at a low cost with as little specialist equipment as necessary. This would make such treatment more accessible in the future. The life course of a woman presents a unique set of medical challenges that are yet to be adequately addressed by the medical field. It is hoped that nanomedicine can provide promising and novel therapeutic applications, to allow physicians and patients to address these challenges more effectively.

For Details https://drug-chemistry.pharmaceuticalconferences.com/

Roza Palv
Program Manager-Pharm Chem 2018
Email: pharmaceuticalchemistry@pharmameetings.com